Back to Newsroom

Alder BioPharmaceuticals to Present at the Leerink Partners 6th Annual Global Healthcare Conference

BOTHELL, Wash., Feb. 09, 2017 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will webcast its presentation at the upcoming Leerink Partners 6th Annual Global Healthcare Conference at 1:00 p.m. ET (10:00 a.m. PT) on Thursday, February 16, 2017 in New York, NY. The presentation will feature a business overview and update by Randall C. Schatzman, Ph.D., president and chief executive officer.

Click here to read the full release